Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47 - PubMed (original) (raw)
. 1999 Dec 1;94(11):3633-43.
Affiliations
- PMID: 10572074
Free article
Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47
M Seiffert et al. Blood. 1999.
Free article
Abstract
Signal-regulatory proteins (SIRPs) comprise a novel transmembrane glycoprotein family involved in the negative regulation of receptor tyrosine kinase-coupled signaling pathways. To analyze the expression and function of SIRPs, we prepared soluble recombinant fusion proteins of the extracellular regions of SIRPalpha1 and SIRPalpha2, as well as a variety of monoclonal antibodies (MoAbs) against these domains. The antibodies reacted predominantly with monocytes, granulocytes, dendritic cells, and their precursors, as well as with bone marrow CD34(+), AC133(+), CD90(+) hematopoietic stem/progenitor cells. In contrast, SIRP expression was absent or significantly reduced on the majority of myeloid blasts from patients with acute myeloid leukemia (AML) or chronic myeloid leukemia (CML). Functional studies showed that the extracellular domains of SIRPalpha1 and SIRPalpha2 support adhesion of a number of primary hematopoietic cells and cell lines. This interaction could be blocked by 4 of 7 SIRPalpha1-reactive MoAbs. In addition, SIRPalpha1 and SIRPalpha2 competed for the same cell binding site, suggesting a common widely expressed SIRP ligand. In an approach to identify this molecule, MoAbs were generated against the SIRP-binding cell line CCRF-CEM, and MoAb CC2C6 was selected because of its capacity to inhibit cell binding to SIRPalpha1. Further analysis showed that this antibody recognized CD47, a ubiquitously expressed plasma membrane protein previously implicated in integrin function, host defense action, and neutrophil migration. In this study, we identify CD47 as the extracellular ligand for human SIRP and show that these two counterreceptors are involved in cellular adhesion.
Similar articles
- Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells.
Seiffert M, Brossart P, Cant C, Cella M, Colonna M, Brugger W, Kanz L, Ullrich A, Bühring HJ. Seiffert M, et al. Blood. 2001 May 1;97(9):2741-9. doi: 10.1182/blood.v97.9.2741. Blood. 2001. PMID: 11313266 - Expression and activation of signal regulatory protein alpha on astrocytomas.
Chen TT, Brown EJ, Huang EJ, Seaman WE. Chen TT, et al. Cancer Res. 2004 Jan 1;64(1):117-27. doi: 10.1158/0008-5472.can-3455-2. Cancer Res. 2004. PMID: 14729615 - Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration.
Liu Y, Bühring HJ, Zen K, Burst SL, Schnell FJ, Williams IR, Parkos CA. Liu Y, et al. J Biol Chem. 2002 Mar 22;277(12):10028-36. doi: 10.1074/jbc.M109720200. Epub 2002 Jan 15. J Biol Chem. 2002. PMID: 11792697 - Signal regulation by family conspiracy.
Cant CA, Ullrich A. Cant CA, et al. Cell Mol Life Sci. 2001 Jan;58(1):117-24. doi: 10.1007/PL00000771. Cell Mol Life Sci. 2001. PMID: 11229810 Free PMC article. Review. - Integrin-associated protein (CD47) and its ligands.
Brown EJ, Frazier WA. Brown EJ, et al. Trends Cell Biol. 2001 Mar;11(3):130-5. doi: 10.1016/s0962-8924(00)01906-1. Trends Cell Biol. 2001. PMID: 11306274 Review.
Cited by
- Targeting CXCR4 and CD47 Receptors: An Overview of New and Old Molecules for a Biological Personalized Anticancer Therapy.
Leo M, Sabatino L. Leo M, et al. Int J Mol Sci. 2022 Oct 18;23(20):12499. doi: 10.3390/ijms232012499. Int J Mol Sci. 2022. PMID: 36293358 Free PMC article. Review. - Inhibitory C-type lectin receptors in myeloid cells.
Redelinghuys P, Brown GD. Redelinghuys P, et al. Immunol Lett. 2011 Apr 30;136(1):1-12. doi: 10.1016/j.imlet.2010.10.005. Epub 2010 Oct 8. Immunol Lett. 2011. PMID: 20934454 Free PMC article. Review. - Homotypic Cell Membrane-Cloaked Biomimetic Nanocarrier for the Targeted Chemotherapy of Hepatocellular Carcinoma.
Liu X, Sun Y, Xu S, Gao X, Kong F, Xu K, Tang B. Liu X, et al. Theranostics. 2019 Aug 12;9(20):5828-5838. doi: 10.7150/thno.34837. eCollection 2019. Theranostics. 2019. PMID: 31534522 Free PMC article. - SIRPγ-CD47 Interaction Positively Regulates the Activation of Human T Cells in Situation of Chronic Stimulation.
Dehmani S, Nerrière-Daguin V, Néel M, Elain-Duret N, Heslan JM, Belarif L, Mary C, Thepenier V, Biteau K, Poirier N, Blancho G, Haspot F. Dehmani S, et al. Front Immunol. 2021 Dec 1;12:732530. doi: 10.3389/fimmu.2021.732530. eCollection 2021. Front Immunol. 2021. PMID: 34925315 Free PMC article. - The aryl hydrocarbon receptor instructs the immunomodulatory profile of a subset of Clec4a4+ eosinophils unique to the small intestine.
Wang WL, Kasamatsu J, Joshita S, Gilfillan S, Di Luccia B, Panda SK, Kim DH, Desai P, Bando JK, Huang SC, Yomogida K, Hoshino H, Fukushima M, Jacobsen EA, Van Dyken SJ, Ruedl C, Cella M, Colonna M. Wang WL, et al. Proc Natl Acad Sci U S A. 2022 Jun 7;119(23):e2204557119. doi: 10.1073/pnas.2204557119. Epub 2022 Jun 2. Proc Natl Acad Sci U S A. 2022. PMID: 35653568 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials